Researchers profile new drug combinations to fight antibiotic-resistant bacteria

Antimicrobial resistance – occurring when pathogens can survive antibiotic treatment – is one of the most rapidly emerging global public health threats today.

After decades fighting Big Tobacco, Cliff Douglas now leads a foundation funded by his former adversaries

“Does it trouble you to answer that question?” one of New York’s highest paid attorneys asked Cliff Douglas, then a 36-year-old activist who had found

May 13, 2024

Variant, Novo to identify metabolic disease treatment targets

Variant’s platform has facilitated the initiation of several new R&D programmes within the company’s pipeline. Credit: shisu_ka / Shutterstock. Variant Bio has entered a multi-year

January 7, 2025

Are back problems influenced by your gut?

Findings suggest gut microbiome dysbiosis may influence lumbar degenerative spondylolisthesis, impacting inflammation and pain management strategies.

October 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.